Explore The Advanced Molecular Era With Us
Why Long-Read Sequencing is Becoming Essential Across Modern Genomics
Whole genome sequencing is foundational to modern research, yet short-read approaches can miss complex, structural, and context-dependent regions of the genome. High-fidelity long-read WGS enables direct observations of structural variants, haplotypes, and genomic context, providing the clarity needed for confident biological and translational insights.
Complete Guide to RNA Sequencing
RNA sequencing has revolutionized transcriptomics research, but success depends on mastering every step from sample collection to data analysis. This comprehensive guide walks you through the entire RNA-Seq workflow, starting with the critical foundation of RNA extraction and comparing leading kits from Qiagen, Omega, Promega, Zymo, and BioEcho. Learn when to choose between Illumina short-read sequencing for quantification and PacBio Iso-Seq for complete isoform characterization. Discover optimal library preparation strategies including polyA selection, rRNA depletion, and specialized protocols for small RNA and circular RNA. Whether you're planning your first experiment or optimizing current protocols, this guide provides the technical specifications, quality control benchmarks, and practical insights needed to generate high-quality, biologically meaningful data.
Advancing Alzheimer’s Research with Generative AI and Single-Cell Genomics: An Admera Health & ODU Partnership
Admera Health and Old Dominion University are advancing Alzheimer’s research through a grant-funded collaboration that combines generative AI, single-cell genomics, and explainable bioinformatics.
Choosing the Right CRO for Your Genomics Research: A Guide for Researchers
Choosing the right CRO can feel overwhelming. Our guide breaks down what researchers should look for—from technical capabilities and regulatory compliance to project communication and true cost. Learn why a U.S.-based, CLIA/CAP-certified partner like Admera Health can streamline your genomics workflows and support your research with confidence.
Unlocking Therapeutic Innovation: How Long-Read Sequencing is Transforming Biopharma
Discover how long-read sequencing technology unlocks complete molecular data for biomarker discovery, gene editing (CRISPR), and optimizing antibody/RNA therapeutics.
The Role of Long-Reads in Transcript Isoform Discovery and RNA Analysis
Discover how PacBio Revio long-read sequencing and Iso-Seq enable full-length transcript analysis, accurate isoform detection, alternative splicing characterization, and fusion transcript discovery, overcoming the limitations of short-read RNA sequencing for advanced transcriptomics research.
Optimizing Budget and Resolution: Cost-Benefit Analysis of Short-Read vs Long-Read Sequencing
Discover how to choose between short-read and long-read sequencing for your genomics project. Compare cost, resolution, and hybrid strategies to maximize data clarity and efficiency with Admera Health.
Decoding the Epigenome: Tools to Unlock Gene Regulation
The genome is the blueprint, but the epigenome tells it how to be read. Chemical modifications like DNA methylation and histone changes act as switches that influence health, development, and disease.
Admera Health provides advanced epigenomic sequencing services—from WGBS and EM-seq to Targeted Methyl-seq, ChIP-seq, and CUT&RUN—delivering reliable results even from challenging samples. Partner with us to unlock the next layer of genetic discovery.
Getting Started with Spatial Transcriptomics: Key Considerations Before You Begin
Thinking about starting a spatial transcriptomics project?
Explore key considerations for choosing the right platform, preparing your samples, and planning your analysis to generate high-quality, spatially resolved gene expression data.
Admera's Commitment to Empowering Your Scientific Breakthroughs Through Our Certified Service Provider Status
Admera Health partners with top Certified Service Providers to deliver cutting-edge genomics with precision, reliability, and innovation—empowering breakthroughs that move science forward.
Accelerating Drug Discovery with Advanced Next-Generation Sequencing & Optimized Workflow
Drug discovery is long, costly, and often slowed by sample loss that compromises NGS data. Admera Health provides expert support and advanced lab services to help biopharma accelerate discoveries with reliable, high-quality results.
Revolutionizing Research Workflows with High-Yield NGS: The Admera Health & BioEcho Advantage
Significant nucleic acid sample loss during extraction often bottlenecks Next-Generation Sequencing (NGS), compromising data quality and delaying discoveries. Admera Health intimately understands this challenge, which is why we're thrilled to partner with BioEcho, innovators of the revolutionary EchoLUTION™ nucleic acid purification technology. This strategic alliance ensures clients achieve higher yields and more robust NGS results right from the first step of their research.
From Insight To Impact: Why Proteomics is Essential in the Age of Multi-Omics
Proteomics is revolutionizing biological discovery by providing real-time insights into protein function, disease mechanisms, and biomarker identification. Explore how proteomics enhances multi-omics research by revealing functional protein insights for biomarker discovery, drug target validation, and disease research.
Decoding Cellular Activity, One Metabolite at a Time
Metabolomics provides a dynamic snapshot of cellular activity, capturing how metabolites reveal the intricate dance of metabolism and environment. Paired with genomics and transcriptomics, this comprehensive approach unlocks unparalleled insights into disease mechanisms, biomarkers, drug response, and microbiome-host interactions. Admera Health bridges the gap between these layers, offering robust NGS services to enhance multi-omics integration, paving the way for impactful discoveries.
The Power of Single-Cell Sequencing with Admera's Expertise and Advanced Platforms
Transform your research with single-cell sequencing. Discover rare cells & complex biology at high resolution. Learn how single-cell sequencing can support diverse research applications from immunology to cancer research
Blowin’ in The Wind: Dr. David Christiani’s Pursuit of Answers for Personalized Medicine
Dr. David Christiani was recently awarded 1st prize for Admera Health’s single-cell sequencing grant contest. We were delighted to sit down with David and learn more about his research on the human genome and the environment with recent interest in personalized medicine to better understand why patients vary in both curative and palliative therapies.